Cargando…

Development and application of classical swine fever virus monoclonal antibodies derived from single B cells

Vaccination with E2 subunit vaccines is currently the main measure to control classical swine fever virus (CSFV), which is an endemic disease, and detection of antibodies against CSFV E2 is the most effective way to evaluate herd immunity. In the present study, the E2 protein was expressed by a bacu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zhongyuan, Zhao, Yongcong, Lv, Jianliang, Pan, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580647/
https://www.ncbi.nlm.nih.gov/pubmed/37845739
http://dx.doi.org/10.1186/s13567-023-01229-y
_version_ 1785121988012933120
author Ma, Zhongyuan
Zhao, Yongcong
Lv, Jianliang
Pan, Li
author_facet Ma, Zhongyuan
Zhao, Yongcong
Lv, Jianliang
Pan, Li
author_sort Ma, Zhongyuan
collection PubMed
description Vaccination with E2 subunit vaccines is currently the main measure to control classical swine fever virus (CSFV), which is an endemic disease, and detection of antibodies against CSFV E2 is the most effective way to evaluate herd immunity. In the present study, the E2 protein was expressed by a baculovirus expression system, and two monoclonal antibodies (mAbs), namely, 3A9 and 4F7, were successfully produced using techniques for the isolation of single B cells from splenocytes from mice immunized with the E2 protein. Moreover, two linear B-cell epitopes, (25)GLTTTWKEYSHDLQL(39) and (259)GNTTVKVHASDERGP(273), reactive to 3A9 and 4F7, respectively, were identified using epitope mapping of the E2 protein. In addition, the diagnostic performance of the two mAbs was evaluated using blocking enzyme-linked immunosorbent assay (bELISA), and the results showed that the two mAbs had high diagnostic specificity (96.08%, 94.38%) and diagnostic sensitivity (97.49%, 95.97%). Together, these findings identify two ideal candidate peptides and matching mAbs for a new method of CSFV diagnosis, which will contribute to the control and eradication of classical swine fever.
format Online
Article
Text
id pubmed-10580647
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105806472023-10-18 Development and application of classical swine fever virus monoclonal antibodies derived from single B cells Ma, Zhongyuan Zhao, Yongcong Lv, Jianliang Pan, Li Vet Res Research Article Vaccination with E2 subunit vaccines is currently the main measure to control classical swine fever virus (CSFV), which is an endemic disease, and detection of antibodies against CSFV E2 is the most effective way to evaluate herd immunity. In the present study, the E2 protein was expressed by a baculovirus expression system, and two monoclonal antibodies (mAbs), namely, 3A9 and 4F7, were successfully produced using techniques for the isolation of single B cells from splenocytes from mice immunized with the E2 protein. Moreover, two linear B-cell epitopes, (25)GLTTTWKEYSHDLQL(39) and (259)GNTTVKVHASDERGP(273), reactive to 3A9 and 4F7, respectively, were identified using epitope mapping of the E2 protein. In addition, the diagnostic performance of the two mAbs was evaluated using blocking enzyme-linked immunosorbent assay (bELISA), and the results showed that the two mAbs had high diagnostic specificity (96.08%, 94.38%) and diagnostic sensitivity (97.49%, 95.97%). Together, these findings identify two ideal candidate peptides and matching mAbs for a new method of CSFV diagnosis, which will contribute to the control and eradication of classical swine fever. BioMed Central 2023-10-16 2023 /pmc/articles/PMC10580647/ /pubmed/37845739 http://dx.doi.org/10.1186/s13567-023-01229-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Ma, Zhongyuan
Zhao, Yongcong
Lv, Jianliang
Pan, Li
Development and application of classical swine fever virus monoclonal antibodies derived from single B cells
title Development and application of classical swine fever virus monoclonal antibodies derived from single B cells
title_full Development and application of classical swine fever virus monoclonal antibodies derived from single B cells
title_fullStr Development and application of classical swine fever virus monoclonal antibodies derived from single B cells
title_full_unstemmed Development and application of classical swine fever virus monoclonal antibodies derived from single B cells
title_short Development and application of classical swine fever virus monoclonal antibodies derived from single B cells
title_sort development and application of classical swine fever virus monoclonal antibodies derived from single b cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580647/
https://www.ncbi.nlm.nih.gov/pubmed/37845739
http://dx.doi.org/10.1186/s13567-023-01229-y
work_keys_str_mv AT mazhongyuan developmentandapplicationofclassicalswinefevervirusmonoclonalantibodiesderivedfromsinglebcells
AT zhaoyongcong developmentandapplicationofclassicalswinefevervirusmonoclonalantibodiesderivedfromsinglebcells
AT lvjianliang developmentandapplicationofclassicalswinefevervirusmonoclonalantibodiesderivedfromsinglebcells
AT panli developmentandapplicationofclassicalswinefevervirusmonoclonalantibodiesderivedfromsinglebcells